News
Rossari Biotech consolidated net profit rises 33.48% in the March 2026 quarter
28-Apr-2026 | 07:28
Sales rise 18.17% to Rs 684.86 crore
Net profit of Rossari Biotech rose 33.48% to Rs 45.97 crore in the quarter ended March 2026 as against Rs 34.44 crore during the previous quarter ended March 2025. Sales rose 18.17% to Rs 684.86 crore in the quarter ended March 2026 as against Rs 579.56 crore during the previous quarter ended March 2025.
For the full year,net profit rose 9.41% to Rs 149.21 crore in the year ended March 2026 as against Rs 136.38 crore during the previous year ended March 2025. Sales rose 15.19% to Rs 2396.37 crore in the year ended March 2026 as against Rs 2080.29 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 684.86 | 579.56 | 18 | 2396.37 | 2080.29 | 15 |
| OPM % | 11.28 | 11.99 | - | 11.93 | 12.74 | - |
| PBDT | 87.77 | 65.93 | 33 | 281.64 | 252.26 | 12 |
| PBT | 64.24 | 47.71 | 35 | 202.52 | 185.19 | 9 |
| NP | 45.97 | 34.44 | 33 | 149.21 | 136.38 | 9 |
Powered by Capital Market - Live News
